4.6 Article

PKCβ modulates ischemia-reperfusion injury in the heart

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease

Katherine R. Tuttle et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Cardiac & Cardiovascular Systems

A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo

Giuseppina Milano et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo

RA Kaiser et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Cardiac & Cardiovascular Systems

Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction

AJ Boyle et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)

Article Pharmacology & Pharmacy

Protein kinase C βII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury

D Omiyi et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Cardiac & Cardiovascular Systems

Central role of PKCβ in neointimal expansion triggered by acute arterial injury

M Andrassy et al.

CIRCULATION RESEARCH (2005)

Article Cardiac & Cardiovascular Systems

Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach

S Takuma et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)